Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1816 | Thyroid cancer | ICEECE2012

Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results

Castelblanco E. , Gallel P. , Ros S. , Gatius S. , Valls J. , De-Cubas A. , Maliszewska A. , Yebra-Pimentel M. , Menarguez J. , Gamallo C. , Opocher G. , Robledo M. , Matias-Guiu X.

Thyroid paraganglioma (TP) is a rare disorder that sometimes poses problems in differential diagnosis with medullary thyroid carcinoma (MTC). So far, differential diagnosis is solved with the help of some markers that are frequently expressed in MTC (TTF1, calcitonin, and CEA). However, some of these markers are not absolutely specific of MTC and may be expressed in other tumors. Here we report 3 new cases of TP and describe our strategy to design a diagnostic immunohistochemi...

ea0029p1825 | Thyroid cancer | ICEECE2012

Prognostic markers in Papillary Thyroid Cancer by immunohistochemistry

Castelblanco E. , Gallel P. , Martinez M. , Barrera L. , Capel I. , Moreno P. , Gimenez G. , Puig-Domingo M. , Bella R. , Porta M. , Halperin I. , Lopez S. , Orellana R. , Cameselle J. , Matias-Guiu X. , Mauricio D. , Robledo M. , Maravall J.

Papillary thyroid cancer (PTC) is the most common endocrine malignancy. Its management has not changed significantly in recent decades, and most patients receive the same treatment. Moreover, there are not alternative treatments for low response or aggressive neoplasias. The availability of reliable prognostic markers that would allow the PTC to be identified based on their aggressiveness at the time of diagnosis would derive in an individualized treatment. In a previous study...